bcp157 tb500 ghk cu TB 500 vs BPC 157: Comprehensive comparison of healing peptides Peptides for Recovery: TB500 vs

DSIP

Clinical trials have demonstrated benefits in: Elderly individuals with cardiovascular and metabolic disease Patients with neurodegenerative disorders Subjects experiencing premature aging or age-associated decline While research outside of Russia is more limited, the available data supports further investigation into its therapeutic potential

Proper storage from day one eliminates this uncertainty and maximizes your treatment outcomes

Key features Selected peptidic fraction from Saccharomyces cerevisiae Clinically proven benefits on a total of 135 subjects Reduction of caloric intake significant after the first weeks (down to -600kcal/day after 8 weeks) Significant weight loss after the first month Weight loss is from fat mass reduction Abdominal fat and waist circumference significantly decrease Water-soluble and heat-resistant